Solution Manual for ASDFGYG ASDFGYG
Statistics for Nursing R ASDFGYG ASDFGYG ASDFGYG
esearch A Workbook fo ASDFGYG ASDFGYG ASDFGYG
r Evidence-
ASDFGYG
Based Practice 3rd Editi
ASDFGYG ASDFGYG ASDFGYG
on Susan Grove Daisha
ASDFGYG ASDFGYG ASDFGYG
,Answer Guidelines for
ASDFGYG ASDFGYG ASDFGYGQuestions ASDFGYG to Be Graded
ASDFGYG ASDFGYG
ASDFGYG ASD
FGYG
inal,
Measurement: Nom
ASDFGYG AS DFG YG
ASDFGYG
A
1
S D F G Y G AS DFG YG
TheASDFGYG questionsA S D F G Y G areASDFGYG inASDFGYG boldASDFGYGfollowedA S D F G Y G byASDFGYG answers.
1. InASDFGYGTableASDFGYG1,ASDFGYGidentifyASDFGYGtheASDFGYGlevelASDFGYGofASDFGYGmeasurementASDFGYGforASDFGYGtheA
SDFGYGcurrentASDFGYGtherapyASDFGYGvariable.ASDFGYGProvideASDFGYGaASDFGYGrationaleASDFGYGforASDFGYGyourASDFG
YGanswer.
Answer:ASDFGYGTheASDFGYGcurrentASDFGYGtherapyASDFGYGvariableASDFGYGwasASDFGYGmeasuredASDFGYGatASDFGYGtheA
SDFGYGnominal ASDFGYGlevel. ASDFGYGThese ASDFGYGdrugASDFGYGcategories ASDFGYGwere ASDFGYGprobably ASDFGYGdevelo
pedASDFGYGtoASDFGYGbeASDFGYGexhaustiveASDFGYGforASDFGYGthisASDFGYGstudyASDFGYGandASDFGYGincludedASDFGYGtheASDFGYGc
ategoriesASDFGYGofASDFGYGdrugsASDFGYGtheASDFGYGsubjectsASDFGYGwereASDFGYGreceiving.ASDFGYGHowever,ASDFGYGth
eASDFGYGcategoriesASDFGYGareASDFGYGnotASDFGYGexclusive,ASDFGYGsinceASDFGYGpatientsASDFGYGareASDFGYGusuallyASDFG
YGon ASDFGYGmore ASDFGYGthanASDFGYGone ASDFGYGcategoryASDFGYG of ASDFGYGthese ASDFGYGdrugs ASDFGYGtoASDFGYGmanag
eASDFGYGtheirASDFGYGhealthASDFGYGproblems.ASDFGYGTheASDFGYGcurrentASDFGYGtherapiesASDFGYGareASDFGYGnotASDFGYG
measuredASDFGYGatASDFGYGtheASDFGYGordinalASDFGYGlevelASDFGYGbecauseASDFGYGtheyASDFGYGcannotASDFGYGbeASDFGYGrankASDFG
YGordered, ASDFGYGsince ASDFGYGno ASDFGYGdrugASDFGYGcategory ASDFGYGcanASDFGYG beASDFGYGconsidered ASDFGYGmore ASDFG
YGor ASDFGYGless ASDFGYGbeneficial ASDFGYGthanASDFGYGanother ASDFGYGdrug ASDFGYGcategoryASDFGYG(seeASDFGYGFigure
ASDFGYG1-1; ASDFGYG Grove ASDFGYG & ASDFGYGGray, ASDFGYG2019).
2. WhatA S D F G Y G isA S D F G Y G theA S D F G Y G modeA S D F G Y G forA S D F G Y G theA S D F G Y G currentA S D F G Y G therapy
A S D F G Y G variableA S D F G Y G inA S D F G Y G thisA S D F G Y G study?A S D F G Y G ProvideA S D F G Y G aA S D F G Y G rationa
leA S D F G Y G forASDFGYGyourASDFGYGanswer.
Answer:ASDFGYG TheASDFGYG modeASDFGYG forASDFGYG currentASDFGYG therapyASDFGYG wasASDFGYG βASDFGYGblocker.ASDFGYGAASDFGY
G totalASDFGYG ofASDFGYG 100ASDFGYG (94%)ASDFGYG ofASDFGYG theASDFGYG cardiacASDFGYG patients
wereA S D F G Y G receivingA S D F G Y G thisA S D F G Y G categoryA S D F G Y G ofA S D F G Y G drug,A S D F G Y G whichA S D F G Y G wa
sA S D F G Y G theA S D F G Y G mostA S D F G Y G commonA S D F G Y G prescribedA S D F G Y G drugA S D F G Y G forA S D F G Y G thisASDFG
YGsample.
3. WhatASDFGYGstatisticsASDFGYGwereASDFGYGconductedASDFGYGtoASDFGYGdescribeASDFGYGtheASDFGYGBMIASDFGYGofASDF
GYGtheASDFGYGcardiacASDFGYGpatientsASDFGYGinASDFGYGthisASDFGYGsample?ASDFGYGDiscussA S D F G Y G whetherA S D F
G Y G theseA S D F G Y G analysisA S D F G Y G techniquesA S D F G Y G wereA S D F G Y G appropriateA S D F G Y G orA S D F G
Y G inappropriate.
Answer:ASDFGYGBMIASDFGYGwasASDFGYGdescribedASDFGYGwithASDFGYGaASDFGYGmeanASDFGYGandASDFGYGstandardASDFGYGde
viationASDFGYG(SD).ASDFGYGBMIASDFGYGmeasurementASDFGYGresultedA S D F G Y G inASDFGYGratio-
levelA S D F G Y G dataA S D F G Y G withA S D F G Y G continuousA S D F G Y G valuesA S D F G Y G andA S D F G Y G anA S D F G Y G absol
uteA S D F G Y G zeroA S D F G Y G (StoneA S D F G Y G &A S D F G Y G Frazier,A S D F G Y G 2017).A S D F G Y G Ratio-
ASDFGYGlevelASDFGYGdataASDFGYGshouldASDFGYGbeASDFGYGanalyzedASDFGYGwithASDFGYGparametricASDFGYGstatisticsASDFGYGs
uchASDFGYGasASDFGYGtheASDFGYGmeanASDFGYGandASDFGYGSDASDFGYG(GroveASDFGYG&ASDFGYGGray,ASDFGYG2017;ASDFGYGKnapp
,ASDFGYG2017).
4. ResearchersASDFGYGusedASDFGYGtheASDFGYGfollowingASDFGYGitemASDFGYGtoASDFGYGmeasureASDFGYGregisteredASDFG
YGnurses’ASDFGYG(RNs)ASDFGYGincomeASDFGYGinASDFGYGaASDFGYGstudy:A S D F G Y G What ASDFGYGcategoryASDFGYGid
entifiesASDFGYGyourASDFGYGcurrentASDFGYGincomeASDFGYGasASDFGYGanASDFGYGRN?
a. LessASDFGYG thanA S D F G Y G $50,000
b. $50,000A S D F G Y G toA S D F G Y G 59,999
,c. $60,000ASDFGYG toASDFGYG 69,999
d. $70,000A S D F G Y G toA S D F G Y G 80,000
e. $80,000A S D F G Y G orASDFG YG greater
WhatA S D F G Y G levelA S D F G Y G ofA S D F G Y G measurementA S D F G Y G isA S D F G Y G thisA S D F G Y G incomeA S D F G Y G
variable?A S D F G Y G DoesA S D F G Y G theA S D F G Y G incomeA S D F G Y G variableA S D F G Y G followA S D F G Y G theASDFGY
GrulesA S D F G Y G outlinedASDFGYGinA S D F G Y G FigureA S D F G Y G 1-
1?A S D F G Y G ProvideA S D F G Y G aASDFGYGrationaleA S D F G Y G forA S D F G Y G yourA S D F G Y G answer.
Answer:ASDFGYGInASDFGYGthisASDFGYGexample,ASDFGYGtheASDFGYGincomeASDFGYGvariableASDFGYGisASDFGYGmeasuredASDFGYG
atASDFGYGtheASDFGYGordinalASDFGYGlevel.ASDFGYGTheASDFGYGincomeASDFGYGcatego-
ASDFGYGriesA S D F G Y G areA S D F G Y G exhaustive,A S D F G Y G rangingA S D F G Y G fromA S D F G Y G lessA S D F G Y G thanA S D F G Y G $50,000
A S D F G Y G toA S D F G Y G greaterA S D F G Y G thanA S D F G Y G $80,000.A S D F G Y G TheA S D F G Y G twoA S D F G Y G open-ended
AGA S D F G Y G 1-1
, AGASDFGYG1-2 AnswerASDFGYGGuidelinesASDFGYG forASDFGYG QuestionsASDFGYG toASDFGYGBeASDFGYGGraded
categoriesASDFGYGensureASDFGYGthatASDFGYGallASDFGYGsalaryASDFGYGlevelsASDFGYGareASDFGYGcovered.ASDFGYGTheASDFGYGca
tegoriesASDFGYGareASDFGYGnotASDFGYGexclusive,ASDFGYGsinceASDFGYGcatego-
ASDFGYGries ASDFGYG(d) ASDFGYGand ASDFGYG(e) ASDFGYGincludeASDFGYG anASDFGYG $80,000 ASDFGYGsalary, ASDFGYGsoASDFGYGstu
dyASDFGYGparticipantsASDFGYGmakingASDFGYG$80,000ASDFGYGmightASDFGYGmarkASDFGYGeitherASDFGYG(d)ASDFGYGorAS
DFGYG(e) ASDFGYGor ASDFGYGbothASDFGYGcategories, ASDFGYGresulting ASDFGYGinASDFGYGerroneous ASDFGYGdata. ASDFGYGCat
egoryASDFGYG(e)ASDFGYGcouldASDFGYGbeASDFGYGchangedA S D F G Y G toASDFGYGgreaterASDFGYGthanASDFGYG$80,000,ASDF
GYGmaking ASDFGYGthe ASDFGYGcategories ASDFGYGexclusive. ASDFGYGThe ASDFGYGcategories ASDFGYGcanASDFGYGbeASDFGYG
rankASDFGYGorderedASDFGYGfromASDFGYGtheASDFGYGlowestASDFGYGsalaryASDFGYGtoASDFGYGtheASDFGYGhighestASDFGYGsal
ary,ASDFGYGwhichASDFGYGisASDFGYGconsistentASDFGYGwithASDFGYGordinalASDFGYGdataASDFGYG(GroveASDFGYG&ASDFGYG
Gray,ASDFGYG2019;ASDFGYGWaltzASDFGYGetASDFGYGal.,ASDFGYG2017).
5. WhatASDFG YG levelA S D F G Y G ofA SD F G YG measurementAS DF G YG isASDFGYG theASDF G YG CDSASDF GYG score?ASDFG YG ProvideA S
D F G Y G aASDFGYG rationaleASDFG YG forASDFG YG yourA S DF G YG answer.
Answer:ASDFGYGTheASDFGYGCDSASDFGYGscoreASDFGYGisASDFGYGatASDFGYGtheASDFGYGintervalASDFGYGlevelASDFGYGofASDFG
YGmeasurement. ASDFGYGThe ASDFGYGCDS ASDFGYGisASDFGYGa ASDFGYG26-
itemASDFGYGLikertASDFGYGscaleASDFGYGdevelopedASDFGYGtoASDFGYGmeasureASDFGYGdepressionASDFGYGinASDFGYGcard
iacASDFGYGpatients.ASDFGYGStudyASDFGYGparticipantsASDFGYGratedASDFGYGtheirASDFGYGsymp-
ASDFGYGtoms ASDFGYGonASDFGYGa ASDFGYGscale ASDFGYGof ASDFGYG1ASDFGYGtoASDFGYG7, ASDFGYG withASDFGYGhigher ASDFGYGnum
bersASDFGYGindicatingASDFGYGincreasedASDFGYGseverityASDFGYGinASDFGYGtheASDFGYGdepressionASDFGYGsymptoms.
ASDFGYGThe ASDFGYGtotal ASDFGYGscores ASDFGYGfor ASDFGYGeachASDFGYGsubject ASDFGYG obtainedASDFGYGfrom ASDFGYGthis A
SDFGYGmulti-
itemASDFGYGscaleASDFGYGareASDFGYGconsideredASDFGYGtoASDFGYGbeASDFGYGatASDFGYGtheASDFGYGintervalASDFGYGlevelASD
FGYGof ASDFGYGmeasurement ASDFGYG(Gray ASDFGYGet ASDFGYGal., ASDFGYG2017; ASDFGYGWaltz ASDFGYG et ASDFGYGal., ASDFGYG2
017).
6. WereASDFGYGnonparametricA S D F G Y G orASDFGYGparametricASDFGYGanalysisASDFGYGtechniquesA S D F G Y G usedAS
DFGYGtoASDFGYGanalyzeASDFGYGtheASDFGYGCDSASDFGYGscoresASDFGYGforA S D F G Y G theA S D F G Y G cardiacA S D F G Y G pat
ientsA S D F G Y G inASDFGYGthisA S D F G Y G study?A S D F G Y G ProvideA S D F G Y G aA S D F G Y G rationaleA S D F G Y G forA S D F
G Y G yourA S D F G Y G answer.
Answer:A S D F G Y G ParametricA S D F G Y G statistics,A S D F G Y G suchA S D F G Y G asA S D F G Y G meanA S D F G Y G andA S D F G
Y G SD,A S D F G Y G wereA S D F G Y G conductedA S D F G Y G toA S D F G Y G describeA S D F G Y G CDSA S D F G Y G scoresASDFGYGf
orASDFGYGstudyASDFGYGparticipantsASDFGYG(seeASDFGYGTableASDFGYG1).ASDFGYGCDSASDFGYGscoresASDFGYGareASDFGYGinterv
al-
levelASDFGYGdataASDFGYGasASDFGYGindicatedASDFGYGinASDFGYGQuestionsASDFGYG5,ASDFGYGsoASDFGYGparametricASDFGYGstatis
ticsASDFGYGareASDFGYGappropriateASDFGYGforASDFGYGthisASDFGYGlevelASDFGYGofASDFGYGdataASDFGYG(GrayASDFGYGetASDFGYGal.,A
SDFGYG2017;ASDFGYGKimASDFGYG&ASDFGYGMallory,ASDFGYG2017).
7. IsA S D F G Y G theA S D F G Y G prevalenceA S D F G Y G ofA S D F G Y G depressionA S D F G Y G linkedA S D F G Y G toA S D F G Y G the
A S D F G Y G NYHAA S D F G Y G class?A S D F G Y G DiscussA S D F G Y G theA S D F G Y G clinicalA S D F G Y G importanceASDFGYG
ofASDFGYGthisASDFGYGresult.
Answer:A S D F G Y G TheA S D F G Y G studyA S D F G Y G narrativeA S D F G Y G indicatedA S D F G Y G thatA S D F G Y G theA S D F G
Y G prevalenceA S D F G Y G ofA S D F G Y G depressionA S D F G Y G increasedA S D F G Y G withA S D F G Y G theASDFGYGgreaterASD
FGYGNYHAASDFGYGclass.ASDFGYGInASDFGYGNYHAASDFGYGclassASDFGYGIII,ASDFGYG64%ASDFGYGofASDFGYGtheASDFGYGsubjectsAS
DFGYGwereASDFGYGdepressed,ASDFGYGwhereasASDFGYG11%ASDFGYGofASDFGYGtheASDFGYGsubjectsASDFGYGwereASDFGYGdepress
edASDFGYGinASDFGYGNYHAASDFGYGclassASDFGYGI.ASDFGYGThus,ASDFGYGasASDFGYGtheASDFGYGNYHAASDFGYGclassASDFGYGincrea
sed,ASDFGYGtheASDFGYGnumberASDFGYGofASDFGYGsub-
ASDFGYGjectsASDFGYGwithASDFGYGdepressionASDFGYGincreased.ASDFGYGThisASDFGYGisASDFGYGanASDFGYGexpectedASDFGYGfindi
ngASDFGYGbecauseASDFGYGasASDFGYGtheASDFGYGNYHAASDFGYGclassASDFGYGincreases,ASDFGYGcardiacASDFGYGpatientsASDFGYG
haveASDFGYGmoreASDFGYGsevereASDFGYGphysicalASDFGYGsymptoms,ASDFGYGwhichASDFGYGusuallyASDFGYGresultASDFGYGinAS
DFGYGemotionalASDFGYGdistress,ASDFGYGsuchASDFGYGasASDFGYGdepression.ASDFGYGNursesASDFGYGneedASDFGYGtoASDFGYGacti
velyASDFGYGassessASDFGYGcardiacASDFGYGpatientsASDFGYGforASDFGYGdepression,ASDFGYGespeciallyASDFGYGthoseA S D F G
Y G inA S D F G Y G higherA S D F G Y G NYHAA S D F G Y G classes,A S D F G Y G soA S D F G Y G theyA S D F G Y G mightA S D F G Y G beA S
D F G Y G diagnosedA S D F G Y G andA S D F G Y G treatedA S D F G Y G asA S D F G Y G needed.
8. WhatA S D F G Y G frequencyA S D F G Y G andA S D F G Y G percentA S D F G Y G ofA S D F G Y G cardiacA S D F G Y G patientsA S
D F G Y G inA S D F G Y G thisA S D F G Y G studyA S D F G Y G wereA S D F G Y G notA S D F G Y G beingA S D F G Y G treatedA S D F G Y G wi
Statistics for Nursing R ASDFGYG ASDFGYG ASDFGYG
esearch A Workbook fo ASDFGYG ASDFGYG ASDFGYG
r Evidence-
ASDFGYG
Based Practice 3rd Editi
ASDFGYG ASDFGYG ASDFGYG
on Susan Grove Daisha
ASDFGYG ASDFGYG ASDFGYG
,Answer Guidelines for
ASDFGYG ASDFGYG ASDFGYGQuestions ASDFGYG to Be Graded
ASDFGYG ASDFGYG
ASDFGYG ASD
FGYG
inal,
Measurement: Nom
ASDFGYG AS DFG YG
ASDFGYG
A
1
S D F G Y G AS DFG YG
TheASDFGYG questionsA S D F G Y G areASDFGYG inASDFGYG boldASDFGYGfollowedA S D F G Y G byASDFGYG answers.
1. InASDFGYGTableASDFGYG1,ASDFGYGidentifyASDFGYGtheASDFGYGlevelASDFGYGofASDFGYGmeasurementASDFGYGforASDFGYGtheA
SDFGYGcurrentASDFGYGtherapyASDFGYGvariable.ASDFGYGProvideASDFGYGaASDFGYGrationaleASDFGYGforASDFGYGyourASDFG
YGanswer.
Answer:ASDFGYGTheASDFGYGcurrentASDFGYGtherapyASDFGYGvariableASDFGYGwasASDFGYGmeasuredASDFGYGatASDFGYGtheA
SDFGYGnominal ASDFGYGlevel. ASDFGYGThese ASDFGYGdrugASDFGYGcategories ASDFGYGwere ASDFGYGprobably ASDFGYGdevelo
pedASDFGYGtoASDFGYGbeASDFGYGexhaustiveASDFGYGforASDFGYGthisASDFGYGstudyASDFGYGandASDFGYGincludedASDFGYGtheASDFGYGc
ategoriesASDFGYGofASDFGYGdrugsASDFGYGtheASDFGYGsubjectsASDFGYGwereASDFGYGreceiving.ASDFGYGHowever,ASDFGYGth
eASDFGYGcategoriesASDFGYGareASDFGYGnotASDFGYGexclusive,ASDFGYGsinceASDFGYGpatientsASDFGYGareASDFGYGusuallyASDFG
YGon ASDFGYGmore ASDFGYGthanASDFGYGone ASDFGYGcategoryASDFGYG of ASDFGYGthese ASDFGYGdrugs ASDFGYGtoASDFGYGmanag
eASDFGYGtheirASDFGYGhealthASDFGYGproblems.ASDFGYGTheASDFGYGcurrentASDFGYGtherapiesASDFGYGareASDFGYGnotASDFGYG
measuredASDFGYGatASDFGYGtheASDFGYGordinalASDFGYGlevelASDFGYGbecauseASDFGYGtheyASDFGYGcannotASDFGYGbeASDFGYGrankASDFG
YGordered, ASDFGYGsince ASDFGYGno ASDFGYGdrugASDFGYGcategory ASDFGYGcanASDFGYG beASDFGYGconsidered ASDFGYGmore ASDFG
YGor ASDFGYGless ASDFGYGbeneficial ASDFGYGthanASDFGYGanother ASDFGYGdrug ASDFGYGcategoryASDFGYG(seeASDFGYGFigure
ASDFGYG1-1; ASDFGYG Grove ASDFGYG & ASDFGYGGray, ASDFGYG2019).
2. WhatA S D F G Y G isA S D F G Y G theA S D F G Y G modeA S D F G Y G forA S D F G Y G theA S D F G Y G currentA S D F G Y G therapy
A S D F G Y G variableA S D F G Y G inA S D F G Y G thisA S D F G Y G study?A S D F G Y G ProvideA S D F G Y G aA S D F G Y G rationa
leA S D F G Y G forASDFGYGyourASDFGYGanswer.
Answer:ASDFGYG TheASDFGYG modeASDFGYG forASDFGYG currentASDFGYG therapyASDFGYG wasASDFGYG βASDFGYGblocker.ASDFGYGAASDFGY
G totalASDFGYG ofASDFGYG 100ASDFGYG (94%)ASDFGYG ofASDFGYG theASDFGYG cardiacASDFGYG patients
wereA S D F G Y G receivingA S D F G Y G thisA S D F G Y G categoryA S D F G Y G ofA S D F G Y G drug,A S D F G Y G whichA S D F G Y G wa
sA S D F G Y G theA S D F G Y G mostA S D F G Y G commonA S D F G Y G prescribedA S D F G Y G drugA S D F G Y G forA S D F G Y G thisASDFG
YGsample.
3. WhatASDFGYGstatisticsASDFGYGwereASDFGYGconductedASDFGYGtoASDFGYGdescribeASDFGYGtheASDFGYGBMIASDFGYGofASDF
GYGtheASDFGYGcardiacASDFGYGpatientsASDFGYGinASDFGYGthisASDFGYGsample?ASDFGYGDiscussA S D F G Y G whetherA S D F
G Y G theseA S D F G Y G analysisA S D F G Y G techniquesA S D F G Y G wereA S D F G Y G appropriateA S D F G Y G orA S D F G
Y G inappropriate.
Answer:ASDFGYGBMIASDFGYGwasASDFGYGdescribedASDFGYGwithASDFGYGaASDFGYGmeanASDFGYGandASDFGYGstandardASDFGYGde
viationASDFGYG(SD).ASDFGYGBMIASDFGYGmeasurementASDFGYGresultedA S D F G Y G inASDFGYGratio-
levelA S D F G Y G dataA S D F G Y G withA S D F G Y G continuousA S D F G Y G valuesA S D F G Y G andA S D F G Y G anA S D F G Y G absol
uteA S D F G Y G zeroA S D F G Y G (StoneA S D F G Y G &A S D F G Y G Frazier,A S D F G Y G 2017).A S D F G Y G Ratio-
ASDFGYGlevelASDFGYGdataASDFGYGshouldASDFGYGbeASDFGYGanalyzedASDFGYGwithASDFGYGparametricASDFGYGstatisticsASDFGYGs
uchASDFGYGasASDFGYGtheASDFGYGmeanASDFGYGandASDFGYGSDASDFGYG(GroveASDFGYG&ASDFGYGGray,ASDFGYG2017;ASDFGYGKnapp
,ASDFGYG2017).
4. ResearchersASDFGYGusedASDFGYGtheASDFGYGfollowingASDFGYGitemASDFGYGtoASDFGYGmeasureASDFGYGregisteredASDFG
YGnurses’ASDFGYG(RNs)ASDFGYGincomeASDFGYGinASDFGYGaASDFGYGstudy:A S D F G Y G What ASDFGYGcategoryASDFGYGid
entifiesASDFGYGyourASDFGYGcurrentASDFGYGincomeASDFGYGasASDFGYGanASDFGYGRN?
a. LessASDFGYG thanA S D F G Y G $50,000
b. $50,000A S D F G Y G toA S D F G Y G 59,999
,c. $60,000ASDFGYG toASDFGYG 69,999
d. $70,000A S D F G Y G toA S D F G Y G 80,000
e. $80,000A S D F G Y G orASDFG YG greater
WhatA S D F G Y G levelA S D F G Y G ofA S D F G Y G measurementA S D F G Y G isA S D F G Y G thisA S D F G Y G incomeA S D F G Y G
variable?A S D F G Y G DoesA S D F G Y G theA S D F G Y G incomeA S D F G Y G variableA S D F G Y G followA S D F G Y G theASDFGY
GrulesA S D F G Y G outlinedASDFGYGinA S D F G Y G FigureA S D F G Y G 1-
1?A S D F G Y G ProvideA S D F G Y G aASDFGYGrationaleA S D F G Y G forA S D F G Y G yourA S D F G Y G answer.
Answer:ASDFGYGInASDFGYGthisASDFGYGexample,ASDFGYGtheASDFGYGincomeASDFGYGvariableASDFGYGisASDFGYGmeasuredASDFGYG
atASDFGYGtheASDFGYGordinalASDFGYGlevel.ASDFGYGTheASDFGYGincomeASDFGYGcatego-
ASDFGYGriesA S D F G Y G areA S D F G Y G exhaustive,A S D F G Y G rangingA S D F G Y G fromA S D F G Y G lessA S D F G Y G thanA S D F G Y G $50,000
A S D F G Y G toA S D F G Y G greaterA S D F G Y G thanA S D F G Y G $80,000.A S D F G Y G TheA S D F G Y G twoA S D F G Y G open-ended
AGA S D F G Y G 1-1
, AGASDFGYG1-2 AnswerASDFGYGGuidelinesASDFGYG forASDFGYG QuestionsASDFGYG toASDFGYGBeASDFGYGGraded
categoriesASDFGYGensureASDFGYGthatASDFGYGallASDFGYGsalaryASDFGYGlevelsASDFGYGareASDFGYGcovered.ASDFGYGTheASDFGYGca
tegoriesASDFGYGareASDFGYGnotASDFGYGexclusive,ASDFGYGsinceASDFGYGcatego-
ASDFGYGries ASDFGYG(d) ASDFGYGand ASDFGYG(e) ASDFGYGincludeASDFGYG anASDFGYG $80,000 ASDFGYGsalary, ASDFGYGsoASDFGYGstu
dyASDFGYGparticipantsASDFGYGmakingASDFGYG$80,000ASDFGYGmightASDFGYGmarkASDFGYGeitherASDFGYG(d)ASDFGYGorAS
DFGYG(e) ASDFGYGor ASDFGYGbothASDFGYGcategories, ASDFGYGresulting ASDFGYGinASDFGYGerroneous ASDFGYGdata. ASDFGYGCat
egoryASDFGYG(e)ASDFGYGcouldASDFGYGbeASDFGYGchangedA S D F G Y G toASDFGYGgreaterASDFGYGthanASDFGYG$80,000,ASDF
GYGmaking ASDFGYGthe ASDFGYGcategories ASDFGYGexclusive. ASDFGYGThe ASDFGYGcategories ASDFGYGcanASDFGYGbeASDFGYG
rankASDFGYGorderedASDFGYGfromASDFGYGtheASDFGYGlowestASDFGYGsalaryASDFGYGtoASDFGYGtheASDFGYGhighestASDFGYGsal
ary,ASDFGYGwhichASDFGYGisASDFGYGconsistentASDFGYGwithASDFGYGordinalASDFGYGdataASDFGYG(GroveASDFGYG&ASDFGYG
Gray,ASDFGYG2019;ASDFGYGWaltzASDFGYGetASDFGYGal.,ASDFGYG2017).
5. WhatASDFG YG levelA S D F G Y G ofA SD F G YG measurementAS DF G YG isASDFGYG theASDF G YG CDSASDF GYG score?ASDFG YG ProvideA S
D F G Y G aASDFGYG rationaleASDFG YG forASDFG YG yourA S DF G YG answer.
Answer:ASDFGYGTheASDFGYGCDSASDFGYGscoreASDFGYGisASDFGYGatASDFGYGtheASDFGYGintervalASDFGYGlevelASDFGYGofASDFG
YGmeasurement. ASDFGYGThe ASDFGYGCDS ASDFGYGisASDFGYGa ASDFGYG26-
itemASDFGYGLikertASDFGYGscaleASDFGYGdevelopedASDFGYGtoASDFGYGmeasureASDFGYGdepressionASDFGYGinASDFGYGcard
iacASDFGYGpatients.ASDFGYGStudyASDFGYGparticipantsASDFGYGratedASDFGYGtheirASDFGYGsymp-
ASDFGYGtoms ASDFGYGonASDFGYGa ASDFGYGscale ASDFGYGof ASDFGYG1ASDFGYGtoASDFGYG7, ASDFGYG withASDFGYGhigher ASDFGYGnum
bersASDFGYGindicatingASDFGYGincreasedASDFGYGseverityASDFGYGinASDFGYGtheASDFGYGdepressionASDFGYGsymptoms.
ASDFGYGThe ASDFGYGtotal ASDFGYGscores ASDFGYGfor ASDFGYGeachASDFGYGsubject ASDFGYG obtainedASDFGYGfrom ASDFGYGthis A
SDFGYGmulti-
itemASDFGYGscaleASDFGYGareASDFGYGconsideredASDFGYGtoASDFGYGbeASDFGYGatASDFGYGtheASDFGYGintervalASDFGYGlevelASD
FGYGof ASDFGYGmeasurement ASDFGYG(Gray ASDFGYGet ASDFGYGal., ASDFGYG2017; ASDFGYGWaltz ASDFGYG et ASDFGYGal., ASDFGYG2
017).
6. WereASDFGYGnonparametricA S D F G Y G orASDFGYGparametricASDFGYGanalysisASDFGYGtechniquesA S D F G Y G usedAS
DFGYGtoASDFGYGanalyzeASDFGYGtheASDFGYGCDSASDFGYGscoresASDFGYGforA S D F G Y G theA S D F G Y G cardiacA S D F G Y G pat
ientsA S D F G Y G inASDFGYGthisA S D F G Y G study?A S D F G Y G ProvideA S D F G Y G aA S D F G Y G rationaleA S D F G Y G forA S D F
G Y G yourA S D F G Y G answer.
Answer:A S D F G Y G ParametricA S D F G Y G statistics,A S D F G Y G suchA S D F G Y G asA S D F G Y G meanA S D F G Y G andA S D F G
Y G SD,A S D F G Y G wereA S D F G Y G conductedA S D F G Y G toA S D F G Y G describeA S D F G Y G CDSA S D F G Y G scoresASDFGYGf
orASDFGYGstudyASDFGYGparticipantsASDFGYG(seeASDFGYGTableASDFGYG1).ASDFGYGCDSASDFGYGscoresASDFGYGareASDFGYGinterv
al-
levelASDFGYGdataASDFGYGasASDFGYGindicatedASDFGYGinASDFGYGQuestionsASDFGYG5,ASDFGYGsoASDFGYGparametricASDFGYGstatis
ticsASDFGYGareASDFGYGappropriateASDFGYGforASDFGYGthisASDFGYGlevelASDFGYGofASDFGYGdataASDFGYG(GrayASDFGYGetASDFGYGal.,A
SDFGYG2017;ASDFGYGKimASDFGYG&ASDFGYGMallory,ASDFGYG2017).
7. IsA S D F G Y G theA S D F G Y G prevalenceA S D F G Y G ofA S D F G Y G depressionA S D F G Y G linkedA S D F G Y G toA S D F G Y G the
A S D F G Y G NYHAA S D F G Y G class?A S D F G Y G DiscussA S D F G Y G theA S D F G Y G clinicalA S D F G Y G importanceASDFGYG
ofASDFGYGthisASDFGYGresult.
Answer:A S D F G Y G TheA S D F G Y G studyA S D F G Y G narrativeA S D F G Y G indicatedA S D F G Y G thatA S D F G Y G theA S D F G
Y G prevalenceA S D F G Y G ofA S D F G Y G depressionA S D F G Y G increasedA S D F G Y G withA S D F G Y G theASDFGYGgreaterASD
FGYGNYHAASDFGYGclass.ASDFGYGInASDFGYGNYHAASDFGYGclassASDFGYGIII,ASDFGYG64%ASDFGYGofASDFGYGtheASDFGYGsubjectsAS
DFGYGwereASDFGYGdepressed,ASDFGYGwhereasASDFGYG11%ASDFGYGofASDFGYGtheASDFGYGsubjectsASDFGYGwereASDFGYGdepress
edASDFGYGinASDFGYGNYHAASDFGYGclassASDFGYGI.ASDFGYGThus,ASDFGYGasASDFGYGtheASDFGYGNYHAASDFGYGclassASDFGYGincrea
sed,ASDFGYGtheASDFGYGnumberASDFGYGofASDFGYGsub-
ASDFGYGjectsASDFGYGwithASDFGYGdepressionASDFGYGincreased.ASDFGYGThisASDFGYGisASDFGYGanASDFGYGexpectedASDFGYGfindi
ngASDFGYGbecauseASDFGYGasASDFGYGtheASDFGYGNYHAASDFGYGclassASDFGYGincreases,ASDFGYGcardiacASDFGYGpatientsASDFGYG
haveASDFGYGmoreASDFGYGsevereASDFGYGphysicalASDFGYGsymptoms,ASDFGYGwhichASDFGYGusuallyASDFGYGresultASDFGYGinAS
DFGYGemotionalASDFGYGdistress,ASDFGYGsuchASDFGYGasASDFGYGdepression.ASDFGYGNursesASDFGYGneedASDFGYGtoASDFGYGacti
velyASDFGYGassessASDFGYGcardiacASDFGYGpatientsASDFGYGforASDFGYGdepression,ASDFGYGespeciallyASDFGYGthoseA S D F G
Y G inA S D F G Y G higherA S D F G Y G NYHAA S D F G Y G classes,A S D F G Y G soA S D F G Y G theyA S D F G Y G mightA S D F G Y G beA S
D F G Y G diagnosedA S D F G Y G andA S D F G Y G treatedA S D F G Y G asA S D F G Y G needed.
8. WhatA S D F G Y G frequencyA S D F G Y G andA S D F G Y G percentA S D F G Y G ofA S D F G Y G cardiacA S D F G Y G patientsA S
D F G Y G inA S D F G Y G thisA S D F G Y G studyA S D F G Y G wereA S D F G Y G notA S D F G Y G beingA S D F G Y G treatedA S D F G Y G wi
